A Study of HG146 Capsule in Chinese Subjects with Relapsed and Refractory Multiple Myeloma
Clinical trial NCT03710915 · TERMINATED
Trial details
- NCT number
- NCT03710915
- Sponsor
- HitGen Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-12
- Primary completion
- 2022-09-28
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.